Samsung Biologics’ upcoming $1.5-billion production plant will be ready for operation by April 2025, five months earlier than previously expected, according to the pharmaceutical...
President Yoon Suk Yeol underscored that South Korea-U.S. ties have been upgraded to a "nuclear-based alliance" amid escalating threats from the North in a...
The first meeting of a joint South Korean-U.S. nuclear deterrence and strategic planning group is expected to take place next month, an informed source...
Samsung Biologics inked a $112.5 million contract manufacturing organization (CMO) letter of intent with an unnamed U.S. biopharmaceutical firm, the Korean company said in...
Reining in North Korea's rising military threats dominated South Korean Defense Minister Lee Jong-sup's talks with defense chiefs from the United States, Japan and...